WHAT´S NEW in Spondyloarthritis?

In this section you will be able to identify the new content uploaded regularly .

Duration 6:03

The Importance of addressing muscloskeletal signs & symptoms in psoriatic arthritis 

Prof. William Tillett

Consultant rheumatologist, royal national hospital for rheumatic diseases senior lecturer, pharmacy and pharmacology, University of Bath, UK

Duration 5:15

The Role of JAKs in SpA

Prof. Eduardo Mysler 

Director of the medical research organization, principal investigator and clinical protocol designer for medical institutions, OMI in Buenos Aires, Argentina 


Duration 7:15

Unmet Needs in Axial SpA & PsA

Prof. Andrew Ostor

Consultant rheumatologist, Cabrini medical cente, and a Melbourne investigator, Emeritus research unit, Melbourne, Australia



Duration 8:05

Upadacitinib for Active Psoriatic Arthritis Refractory to Biologics (SELECT-PSA 2)

Prof. Philip Mease

Swedish medical center/ Providence St Joseph Health and university of Washington, Seattle, Washington


Duration 7:21

Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis (SELECT-PSA 1)

Prof. Ian Mclnnes

University of Glasgow




Duration 8:00

Efficacy and Safety of Upadacitinib in a randomized, double-blind, placebo-controled,multicenter phase 2/3 clinical study of patients with active ankylosing spondylitis (SELECT-AXIS 1)

Prof. Desiree Van Der Heijde

Leiden University Medical Center, Leiden, The Netherlands

Duration 1:20

Psoriatic Arthritis Disease State




Duration 1:11

Ankylosing Spondylarthritis Disease State



Duration 1:44

Exploring the JAK-STAT Pathway




Duration 3:44

RA EVEREST: Striving for the highest level of care